These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17559909)

  • 1. Matrix metalloproteinases-2, -3 and -9 in human term placenta.
    Demir-Weusten AY; Seval Y; Kaufmann P; Demir R; Yucel G; Huppertz B
    Acta Histochem; 2007; 109(5):403-12. PubMed ID: 17559909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor.
    Xu P; Alfaidy N; Challis JR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1353-61. PubMed ID: 11889208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of matrix metalloproteinase (MMP)-2, MMP-14 and tissue inhibitor of matrix metalloproteinase (TIMP)-2 during bovine placentation and at term with or without placental retention.
    Dilly M; Hambruch N; Shenavai S; Schuler G; Froehlich R; Haeger JD; Ozalp GR; Pfarrer C
    Theriogenology; 2011 Apr; 75(6):1104-14. PubMed ID: 21247626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in matrix metalloproteinase (MMP)-2 and MMP-9 in the fetal amnion and chorion during gestation and at term and preterm labor.
    Yonemoto H; Young CB; Ross JT; Guilbert LL; Fairclough RJ; Olson DM
    Placenta; 2006; 27(6-7):669-77. PubMed ID: 16061282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium.
    Polette M; Nawrocki B; Pintiaux A; Massenat C; Maquoi E; Volders L; Schaaps JP; Birembaut P; Foidart JM
    Lab Invest; 1994 Dec; 71(6):838-46. PubMed ID: 7807965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitor-2 of matrix metalloproteinases (TIMP-2) in the placenta and interplacental uterine wall in normal cows and in cattle with retention of fetal membranes.
    Walter I; Boos A
    Placenta; 2001 May; 22(5):473-83. PubMed ID: 11373158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the expression and enzyme activity of matrix metalloproteinase-7 in fetal membranes during premature rupture of membranes at term in humans.
    Nishihara S; Someya A; Yonemoto H; Ota A; Itoh S; Nagaoka I; Takeda S
    Reprod Sci; 2008 Feb; 15(2):156-65. PubMed ID: 18276951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase (MMP)-2 and MMP-9 activity in the canine uterus before and during placentation.
    Beceriklisoy HB; Walter I; Schäfer-Somi S; Miller I; Kanca H; Izgür H; Aslan S
    Reprod Domest Anim; 2007 Dec; 42(6):654-9. PubMed ID: 17976075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of extracellular matrix metalloproteinase inducer in human placenta and fetal membranes at term labor.
    Li W; Alfaidy N; Challis JR
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2897-904. PubMed ID: 15181074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased matrix metalloproteinases 2 and 9 in placenta of diabetic rats at midgestation.
    Pustovrh MC; Jawerbaum A; Capobianco E; White V; López-Costa JJ; González E
    Placenta; 2005 Apr; 26(4):339-48. PubMed ID: 15823620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of messenger RNA expression of matrix metalloproteinases (MMP-2 and MMP-9), tissue inhibitor-2 of matrix metalloproteinases (TIMP-2), and steroidogenic enzymes in bovine placentomes during gestation and postpartum.
    Takagi M; Yamamoto D; Ohtani M; Miyamoto A
    Mol Reprod Dev; 2007 Jul; 74(7):801-7. PubMed ID: 17154296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy.
    Naruse K; Lash GE; Innes BA; Otun HA; Searle RF; Robson SC; Bulmer JN
    Hum Reprod; 2009 Mar; 24(3):553-61. PubMed ID: 19088110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases in the vein wall.
    Kowalewski R; Sobolewski K; Wolanska M; Gacko M
    Int Angiol; 2004 Jun; 23(2):164-9. PubMed ID: 15507895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix components and matrix degrading enzymes in the feline placenta during gestation.
    Walter I; Schönkypl S
    Placenta; 2006; 27(2-3):291-306. PubMed ID: 16338474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial characterization of the microenvironment that regulates connective tissue degradation in amniochorion during normal human labor.
    Estrada-Gutierrez G; Zaga V; Gonzalez-Jimenez MA; Beltran-Montoya J; Maida-Claros R; Giono-Cerezo S; Vadillo-Ortega F
    Matrix Biol; 2005 Jun; 24(4):306-12. PubMed ID: 15955681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of matrix metalloproteinases 2 and 9 activities by peroxynitrites in term placentas from type 2 diabetic patients.
    Capobianco E; White V; Sosa M; Di Marco I; Basualdo MN; Faingold MC; Jawerbaum A
    Reprod Sci; 2012 Aug; 19(8):814-22. PubMed ID: 22344735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary treatments enriched in olive and safflower oils regulate seric and placental matrix metalloproteinases in maternal diabetes.
    Martinez N; Sosa M; Higa R; Fornes D; Capobianco E; Jawerbaum A
    Placenta; 2012 Jan; 33(1):8-16. PubMed ID: 22098918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
    Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
    BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of activities of matrix metalloproteinases-9 and -2, and the tissue inhibitors of MMPs in fetal fluid compartments during gestation and at parturition in the mare.
    Oddsdóttir C; Riley SC; Leask R; Shaw DJ; Aurich C; Palm F; Fowden AL; Ricketts SW; Watson ED
    Theriogenology; 2011 Apr; 75(6):1130-8. PubMed ID: 21220153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transition from the latent to the active enzymatic form as a model of regulation of extracellular matrix degradation in the chorioamnion during human labor].
    Vadillo Ortega F; Hernández Miranda A; Bermejo Martínez L; Beltrán Montoya J; González Avila G
    Ginecol Obstet Mex; 1995 Apr; 63():166-72. PubMed ID: 7768474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.